Intracellular Ca^<2+> regulation in the myocardium with ryanodine receptor type 2(+/-) heterozygous mouse
兰尼定受体2型(/-)杂合小鼠心肌细胞内Ca^<2>调节
基本信息
- 批准号:13670048
- 负责人:
- 金额:$ 2.18万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We produced knockout mouse with ryanodine receptor type 2 (RyR-2(+/-)) and explored the cardiac functions of the heart. In Langenforff perfusion, we could not detect any significant changes of the parameters of pressure (dP/dt, -dP/dt) and end diastolic volume in the heart in K.O. mouse. We concluded that the partial deletion of RyR-2 is well compensated. Then, we focused on the Ca^<2+> pump of sarcoplasmic reteiculum (SERCA2a) which plays an important role in the regulation of [Ca^<2+>]i. We overexpressed SERCA 2a (TG) and explored its cardiac functions. In TG, &P/dt and-dP/dt were larger than those in nonTG (NTG). In TG, cardiac hypertrophy was significantly reduced when the heart was loaded with higher pressure. Thus, SERCA2a plays a key role to improve pathophysiological adaptation. We dissected papillary muscles from the left ventricle of TO and measured Ca^<2+> transient(CaT) with aequorin. The peak of CaT was larger than that of NTG. The time courses of CaT in TG were faster than those in NTG. In NTG, isoprenaline increased the peak of CaT and shortened the time course of CaT. However, no significant changes of these parameters were observed in TO. In CO_2 acidosis, contraction was decreased although CaT was increased in NTG. In TO, similar changes were observed but the inhibition of contraction in acidosis was reduced. The recovery of contraction was also better than that in NTG. Thus, SERCA2a plays a pivotal role under pathophysiological condition.
我们用Ryanodine受体2(RyR-2(+/-))基因敲除小鼠,并探讨了心脏的心功能。Langenforff灌流时,K.O.大鼠心脏压力(dP/dt,-dP/dt)和舒张末期容积(dD)无明显变化。老鼠.我们得出结论,RyR-2的部分缺失得到了很好的补偿。然后,我们重点研究了肌浆网Ca^2+泵(SERCA 2a)在[Ca^2+]i调节中的重要作用。我们过量表达了SERCA 2a(TG)并研究了其心脏功能。TG组的&P/dt和-dP/dt均大于非TG组(NTG)。在TG中,当心脏负荷较高的压力时,心脏肥大显著减少。因此,SERCA 2a在改善病理生理适应中起着关键作用。我们从TO的左心室解剖乳头肌,并用水母发光蛋白测量Ca^2+瞬时(CaT)。CaT的峰值大于NTG。TG组CaT的时程明显快于NTG组。异丙肾上腺素使NTG的CaT峰值增加,时间缩短,而TO的上述参数无明显变化。在CO_2酸中毒时,NTG虽使CaT升高,但收缩功能减弱。在TO中,观察到类似的变化,但酸中毒时收缩抑制减少。收缩的恢复也好于NTG。因此,SERCA 2a在病理生理条件下起着关键作用。
项目成果
期刊论文数量(33)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kusakari Y: "The Mechanism of an Increasing in Ca^<2+> Responsiveness by α_1-Adrenergic Stimulation in Rat Ventricular Myocytes."Jpn J Physiol. 52(6). 531-539 (2002)
Kusakari Y:“通过α_1-肾上腺素刺激大鼠心室肌细胞增加Ca ^ 2+ 反应性的机制”。Jpn J Physiol。52(6)(2002)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kusakari Y: "The mechanism of an increase in Ca^<2+> responsiveness by α_1-adrenergic stimulation in rat ventricular myocytes"Jpn J Physiol. 52(6). 531-539 (2002)
Kusakari Y:“通过α_1-肾上腺素刺激大鼠心室肌细胞的Ca ^ 2+ 反应性增加的机制”Jpn J Physiol.52(6)(2002)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kurihara S: "Measurement of intracellular Ca^<2+> signal in cardiac muscles using aequorin"Japanese Journal Electrocardiology. 21. S-2-3-S-2-14 (2001)
Kurihara S:“使用水母发光蛋白测量心肌中的细胞内Ca ^ 2 信号”,日本电心脏病学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
草刈洋一郎: "不全心における収縮障害の細胞内メカニズム-SERCA2aを中心として-"日本薬理学雑誌. 123(2). 87-93 (2004)
Yoichiro Kusakari:“衰竭心脏收缩功能障碍的细胞内机制 - 关注 SERCA2a”《日本药理学杂志》123(2) 87-93 (2004)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Asahi M: "Regulation of Sarco(endo)plasmic Reticulum Ca^<2+> Adenosine Trip hosphatase by Phospholamban and Sarcolipin : Implication for Cardiac Hypertrophy and Failure."Trends Cradiovasc Med. 13(4). 152-157 (2003)
Asahi M:“磷酸酶和肌脂蛋白对肌(内)质网 Ca^<2> 腺苷磷酸酶的调节:对心脏肥大和衰竭的影响。”Trends Cradiovasc Med。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KURIHARA Satoshi其他文献
KURIHARA Satoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KURIHARA Satoshi', 18)}}的其他基金
Proposal of adaptive coordination formation control mechanism for multiagent planning
多智能体规划自适应协调编队控制机制的提出
- 批准号:
23300058 - 财政年份:2011
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Proposal of hierarchy structure emergence mechanism for large scale complex systems
大规模复杂系统层次结构涌现机制的提出
- 批准号:
23650071 - 财政年份:2011
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Molecular mechanisms of an improvement in prognosis in the mouse model of dilated cardiomyopathy treated by inhibition of the RAA system
抑制 RAA 系统治疗扩张型心肌病小鼠模型预后改善的分子机制
- 批准号:
22300130 - 财政年份:2010
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Proposal of top-down controllable multiagent coordination mechanism
自上而下的可控多主体协调机制的提出
- 批准号:
20500133 - 财政年份:2008
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanism of contractile dysfunction and the alteration of intracellular Ca^<2+> handling caused by mutation of cardiac troponin T
心肌肌钙蛋白T突变引起收缩功能障碍及细胞内Ca^2处理改变的分子机制
- 批准号:
19500357 - 财政年份:2007
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of Ca^<2+> uptake by sarcolipin in cardiac sarcoplasmic reticulum.
心脏肌浆网肌磷脂摄取Ca ^ 2 的分子机制。
- 批准号:
16500269 - 财政年份:2004
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Research on assessment system of medical dental students' clinical competence before entering clinical clerkship
医学牙科学生进入临床实习前临床能力评价体系研究
- 批准号:
13800002 - 财政年份:2001
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Special Purposes
A Basis Study of Ethnographies in Southwest of China -Mainly Yunnan Area-
西南地区——主要是云南地区——民族志基础研究
- 批准号:
13610368 - 财政年份:2001
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Production of new recombinant aequorin and its physiological application
新型重组水母发光蛋白的制备及其生理应用
- 批准号:
13557004 - 财政年份:2001
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular Mechanisms of Active Cross-bridge-dependent Regulation of Ca affinity of Cardiac Troponin
心肌肌钙蛋白 Ca 亲和力的主动跨桥依赖性调节的分子机制
- 批准号:
10470010 - 财政年份:1998
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
相似国自然基金
维持心肌能量代谢稳态对于降低老龄脓毒血症大鼠病死率的意义
- 批准号:30801210
- 批准年份:2008
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Examining the Function of a Novel Protein in the Cardiac Junctional Membrane Complex
检查心脏连接膜复合体中新型蛋白质的功能
- 批准号:
10749672 - 财政年份:2024
- 资助金额:
$ 2.18万 - 项目类别:
Clarifying Pathophysiology of Atrial Fibrillation by Tissue Multi-Omics Analysis of Atrial Myocardium
通过心房心肌的组织多组学分析阐明心房颤动的病理生理学
- 批准号:
23KJ0378 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Nanowired humam cardiac organoid derived exosomes for heart repair
纳米线人类心脏类器官衍生的外泌体用于心脏修复
- 批准号:
10639040 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
A role for cardiomyocyte pannexin 1 in non-ischemic heart failure
心肌细胞pannexin 1在非缺血性心力衰竭中的作用
- 批准号:
10680109 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Thick and Thin Filament Dysfunction in Obese Heart Failure with Preserved Ejection Fraction
射血分数保留的肥胖性心力衰竭的粗细丝功能障碍
- 批准号:
10678204 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Parallel Characterization of Genetic Variants in Chemotherapy-Induced Cardiotoxicity Using iPSCs
使用 iPSC 并行表征化疗引起的心脏毒性中的遗传变异
- 批准号:
10663613 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Oxidative Stress and Mitochondrial Dysfunction in Chemogenetic Heart Failure
化学遗传性心力衰竭中的氧化应激和线粒体功能障碍
- 批准号:
10643012 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Differences in Women and Men with Atrial Fibrillation
女性和男性房颤患者的差异
- 批准号:
10822952 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Temporospatial Single-Cell Characterization of Angiogenesis and Myocardial Regeneration in Small and Large Mammals
小型和大型哺乳动物血管生成和心肌再生的时空单细胞表征
- 批准号:
10751870 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Modulators of cardiomyocyte structure to promote functional recovery during cardiac regeneration and repair
心肌细胞结构调节剂促进心脏再生和修复过程中的功能恢复
- 批准号:
10751640 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:














{{item.name}}会员




